patients with cartilage defects

Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...

Strokes are the second leading cause of death and the third leading cause of disabilities globally, according to the World Health Organization.To fi...

LG Innotek, a leading South Korean electronics parts maker, said on Wednesday it developed an artificial intelligence (AI) system that can filter ou...

SEOUL—A North Korean diplomat posted in Cuba defected to South Korea with his family late last year, officials said this week, a rare esc...

PhyxUp Health Inc., an early stage South Korean digital healthcare startup, will soon close a pre-seed funding round, said its founder and chief, wh...

South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., announced on Wednesday that it unveiled its testing solution PerfecTwin ...

South Korea's POSCO E&C has developed a solution for apartment exterior wall maintenance using drones.The company announced on Tuesday that it h...

South Korean electronic parts manufacturer LG Innotek announced on Tuesday it has implemented an artificial intelligence (AI) analysis system to qui...

South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...

South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...

South Korea’s top online portal Naver Corp. said on Wednesday it is strengthening its short-form content service on surging demand for video c...

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

South Korean government has set a goal to expand medical service exports by attracting 700,000 foreign patients and receiving 70 applications of ove...

South Korean President Yoon Suk Yeol on Thursday declared an end to most COVID-19 restrictions including mandatory quarantine for patients of the pa...

South Korea's medical tourism industry, which experienced a severe setback due to the COVID-19 pandemic, has shown considerable recovery, with the n...

As demand for botulinum toxin for aesthetic purposes is globally increasing, safe use of the drug has emerged as one of the most important issues in...

South Korea's Ministry of Food and Drug Safety announced on Wednesday that it has approved the cognitive therapy software "WELT-I" developed by We...

South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...

South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...

South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...

On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...

The Seoul Metropolitan Government is pursuing a "fusion Hanok" project of building 10 Hanok (traditional Korean architecture) villages in the capita...

South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...

Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...

South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...

South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...

Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...